Quarterly report · Q1
7776.TEDINET S100QQQQ
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥31m | 2023-01-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥126m | 2022-01-01 → 2022-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥38m | 2022-01-01 → 2022-03-31 | Standalone | Net sales |
| Operating income | −¥182m | 2023-01-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥192m | 2022-01-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥196m | 2022-01-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥198m | 2022-01-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥760m | 2022-01-01 → 2022-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥199m | 2022-01-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥2.0bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2022-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥399m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥366m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥946m | at 2022-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-6.81 | 2023-01-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.98 | 2022-01-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 27,659,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 18,468,119 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥54m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥115m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥13m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | −¥128m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥55m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥116m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥38m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥38m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥21m |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥38m |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥38m |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | −¥137m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 305
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember | 30446000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember | 249000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 30696000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember | 30696000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember | -13364000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember | -114667000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | -128032000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | -53667000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember | -181700000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-05-15 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第23期第１四半期（自 2023年１月１日 至 2023年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社セルシード | |
| Company name in english cover page | FilingDateInstant | CellSeed Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 橋本 せつ子 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都江東区青海二丁目５番10号テレコムセンタービル | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6380-7490 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営管理部長 畑中 格 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都江東区青海二丁目５番10号テレコムセンタービル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6380-7490 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理部長 畑中 格 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24158 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 77760 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社セルシード | |
| Filer name in english | FilingDateInstant | CellSeed Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2023-01-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |